Jasper Therapeutics, Inc. (JSPR) Reports In-Line Q2 EPS

Jasper Therapeutics, Inc. (NASDAQ: JSPR) reported Q2 EPS of ($0.15), in-line with the analyst estimate of ($0.15).

For earnings history and earnings-related data on Jasper Therapeutics, Inc. (JSPR) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Fifth Third Bancorp (FITB) Misses Q2 EPS by 1c
• Freedom Broker Upgrades Morgan Stanley (MS) to Buy